Today, clinical trial teams and sites rely on a collection of siloed point solutions, creating redundancy and inefficiency. What if you could build a study once, enter data once, and do everything in one place?
Tomorrow's clinical trials, today
Understanding the positive impact to both clinical data quality and the patient experience made by a shift to decentralized approaches is the first step towards the future of clinical trials.Explore DCT
The only platform that truly unifies people, processes, and data to simplify and accelerate the clinical trials of today and in the future.Explore Clinical One
Market research conducted in 2021 provides valuable insight into the impact of adaptations made in clinical trials during the pandemic.Explore the Research Findings
“Cost, time efficiency, and the simplicity of use and design were really important to us.”
Associate Director Clinical Development, Oyster Point Pharmaceuticals
Collect data sets from any source and harmonize them in one place to draw valuable clinical insight.Explore Data Collection
Select and activate sites in record time, while monitoring key milestones to keep budgets and timelines on track.Explore Study Startup
Automatically reconcile data and maintain complete traceability with one source for clinical trial data.Explore Clinical Data Management
Craig Morgan, Oracle Health Sciences Marketing
The instinct to turn to Excel for analytical tasks is undeniable given its ubiquity, making it the default analysis tool of choice. But is Excel the right tool to use for planning and collection of clinical data?Read the complete post
Every organization has different requirements and expectations that drive their technology investments, which must be met to ensure success. Oracle Health Sciences Consulting is here to support that journey and make sure you get the most out of your technology investment.
See what clinical operations professionals had to say about the opportunities and concerns regarding decentralized clinical trial methods.
ICH E6 (R3) is coming at a time when life science organizations still are struggling to adopt ICH E6 (R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
Get the latest insights and best practices to drive your clinical success.
Explore technical support contacts and resources.
Hear from thought leaders on trends in life sciences.
Contact us about clinical research and pharmacovigilance.